Ansiedad, depresión y su relación con el dolor y la gravedad de la fibromialgia

Referencias bibliográficas

• Abiodun, O. A. (1994). A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. British Journal of Psychiatry, 165, 669-672.
• Aguglia, A., Salvi, V., Maina, G., Rossetto, I., & Aguglia, E. (2010). Fibromyalgia syndrome and depressive symptoms: Comorbidity and clinical correlates. Journal of Affective Disorders, 128, 262-266
• Alonso, J., Prieto, L., & Anto, J. M. (1995). The Spanish version of the SF-36 Health Survey questionnaire: An instrument for measuring clinical results. Medicina Clínica, 104, 771-776.
• Aparicio,V. A., Ortega, F. B., Carbonell-Baeza, A., Camiletti, D., Ruiz, J. R., & DelgadoFernandez, M. (2011). Relationship of weight status with mental and physical health in female fibromyalgia patients. Obesity Facts, 4, 443-448.
• Aparicio, V. A., Ortega, F. B., Carbonell-Baeza, A., Gatto-Cardia, C., Sjöström, M., Ruiz, J. R., & Delgado-Fernández, M. (2011). Fibromyalgia´s key symptoms in normal weight, overweight and obese female patients. Pain Management Nursing. Recuperado el 20 de septiembre de 2012, desde http://www.sciencedirect.com/science/article/pii/S1524904211001287.
• Arnold, L. M. (2008). Management of fibromyalgia and comorbid psychiatric disorders. Journal of Clinical Psychiatry, 69, 2, 14-19.
• Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005). A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain, 119, 5-15.
• Bennett, R. (2005). The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clinical and Experimental Rheumatology, 23, 154-162.
• Bennett, R. M., Bushmakin, A. G., Cappelleri, J. C., Zlateva, G., & Sadosky, A. B. (2009). Minimal clinically important difference in the fibromyalgia impact questionnaire. Journal of Rheumatology, 36, 1304-1311.
• Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007). An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders, 8, 27.
• Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52, 69-77.
• Bradley, L. A. (2008). Pathophysiologic mechanisms of fibromyalgia and its related disorders. Journal of Clinical Psychiatry, 69, 6-13.
• Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: development and validation. Journal of Rheumatology, 18, 728-733.
• Cuevas, A. M., López, F., García, A., & Díaz, M. C. (2008). Personalidad y estrategias de afrontamiento en pacientes con fibromialgia. Behavioral Psychology/Psicología Conductual, 16, 289-306.
• Cuevas, A. M. & Torrecillas, F. (2008, marzo). Personality and pain impact in fibromyalgia patients [Personalidad e impacto del dolor en pacientes con fibromialgia]. Poster presentado en el II Congreso Hispano Cubano de Psicología de la Salud: diversidad teórico práctica en la Psicología actual, Granada, Spain.
• Edwards, R. R., Calahan, C., Mensing, G., Smith, M., & Haythornthwaite, J. A. (2011). Pain, catastrophizing, and depression in the rheumatic diseases. Nature Reviews in Rheumatolology, 7, 216-224
• Ehrlich, G. E. (2003). Fibromyalgia, a virtual disease. Clinical Rheumatology, 22, 8-11. Evers, A. W., Kraaimaat, F. W., van Riel, P. L., & de Jong, A. J. (2002). Tailored cognitivebehavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain, 100, 141-153.
• Giesecke, T., Gracely, R. H., Williams, D. A., Geisser, M. E., Petzke, F. W., & Clauw, D. J. (2005). The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis and Rheumatism, 52, 1577-1584.
• Glombiewski, J. A., Sawyer, A. T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S. G. (2010). Psychological treatments for fibromyalgia: a meta-analysis. Pain, 151, 280-295.
• Gormsen, L., Rosenberg, R., Bach, F. W., & Jensen, T. S. (2010). Depression, anxiety, healthrelated quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. European Journal of Pain, 14, 121-128.
• Jackson, J. L., O'Malley, P. G., & Kroenke, K. (2006). Antidepressants and cognitivebehavioral therapy for symptom syndromes. CNS Spectrum, 11, 212-222.
• Jenkinson, C., Coulter, A., & Wright, L. (1993). Short form 36 (SF36) Health Survey Questionnaire: normative data for adults of working age. British Medical Journal, 29, 1437-1440.
• Jensen, K. B., Petzke, F., Carville, S., Fransson, P., Marcus, H., Williams, S. C., Choy, E., Mainguy, Y., Gracely, R., Ingvar, M., & Kosek, E. (2010). Anxiety and depressive symptoms in fibromyalgia are related to low health esteem but not to pain sensitivity or cerebral processing of pain. Arthritis and Rheumatism, 62, 3488-3495.
• Mazza, M., Mazza, O., Pomponi, M., Di Nicola, M., Padua, L., Vicini, M., Bria, P., & Mazza, S. (2009). What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? Comprehensive Psychiatry, 50, 240-244.
• Merskey, H. (2008). Social influences on the concept of fibromyalgia. CNS Spectrum, 13, 18-21.
• Quintana, J. M., Padierna, A., Esteban, C., Arostegui, I., Bilbao, A., & Ruiz, I. (2003). Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 107, 216-221.
• Ramírez, C. & Valdivia, V. (2008). Evaluación del funcionamiento diario en pacientes con dolor crónico. Behavioral Psychology/Psicología Conductual, 11, 283-291.
• Rivera, J. & Gonzalez, T. (2004). The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clinical and Experimental Rheumatology, 22, 554-560.
• Roth, R. S., Geisser, M. E., Theisen-Goodvich, M., & Dixon, P. J. (2005). Cognitive complaints are associated with depression, fatigue, female sex, and pain catastrophizing in patients with chronic pain. Archives of Physical Medicine and Rehabilitation, 86, 1147-1154.
• Russell, I. J., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D.J., Chappell, A.S., & Arnold, L.M. (2008). Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain, 136, 432-444.
• Schweinhardt, P., Kalk, N., Wartolowska, K., Chessell, I., Wordsworth, P., & Tracey, I. (2008). Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage, 40, 759-766.
• Silverman, S. L., Harnett, J., Zlateva, G. & Mardekian, J. (2010). Identifying FibromyalgiaAssociated Symptoms and Conditions from a Clinical Perspective: A step toward evaluating healthcare resource utilization in fibromyalgia. Pain Practice, 10, 520-529.
• Stisi, S., Venditti, C., & Sarracco, I. (2008). Distress influence in fibromyalgia. Reumatismo, 60, 274-281.
• Ware, J. E. & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483.
• Wilson, H. D., Robinson, J. P., & Turk, D. C. (2009). Toward the identification of symptom patterns in people with fibromyalgia. Arthritis and Rheumatism, 61, 527-534.
• Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S.M., Abeles, M., & Clark, P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism, 33, 160-172.
• Zigmond, A. S. & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.